• Citer

HER-2/neu-derived peptide 884-899 is expressed by human breast, colorectal and pancreatic adenocarcinomas and is recognized by in-vitro-induced specific CD4(+) T cell clones.

par Perez, Sonia;Sotiropoulou, Panagiota ;Sotiriadou, Nectaria N;Mamalaki, Avgi;Gritzapis, Angelos D;Echner, Hartmut;Voelter, Wolfgang;Pawelec, Graham;Papamichail, Michael;Baxevanis, Constantin N
Référence Cancer immunology and immunotherapy, 50, 11, page (615-624)
Publication Publié, 2002-01

Article révisé par les pairs

• Détails
• Contenu

Titre:	HER-2/neu-derived peptide 884-899 is expressed by human breast, colorectal and pancreatic adenocarcinomas and is recognized by in-vitro-induced specific CD4(+) T cell clones.
Auteur:	Perez, Sonia; Sotiropoulou, Panagiota; Sotiriadou, Nectaria N; Mamalaki, Avgi; Gritzapis, Angelos D; Echner, Hartmut; Voelter, Wolfgang; Pawelec, Graham; Papamichail, Michael; Baxevanis, Constantin N
Informations sur la publication:	Cancer immunology and immunotherapy, 50, 11, page (615-624)
Statut de publication:	Publié, 2002-01
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Adenocarcinoma -- immunology -- pathology
	Antigen Presentation
	Antigens, Neoplasm -- immunology
	Breast Neoplasms -- immunology -- pathology
	CD4-Positive T-Lymphocytes -- immunology
	Colorectal Neoplasms -- immunology -- pathology
	Cytotoxicity, Immunologic
	Dendritic Cells -- immunology
	Female
	Humans
	Immunotherapy, Adoptive
	Pancreatic Neoplasms -- immunology -- pathology
	Peptide Fragments -- immunology
	Receptor, erbB-2 -- immunology
	Tumor Cells, Cultured
Note générale:	Journal Article
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:0340-7004
	info:doi/10.1007/s002620100225
	info:pmid/11807625